LENZ Therapeutics
Yahoo Finance • 21 days ago
LENZ Therapeutics Q4 Earnings Call Highlights
LENZ Therapeutics logo Executives from LENZ Therapeutics (NASDAQ:LENZ) used the company’s latest earnings call to provide an update on the early U.S. launch of its presbyopia eye drop, emphasizing initial physician adoption, early refill... Full story
Yahoo Finance • 21 days ago
Why Lenz Therapeutics Stock Crashed Today
Lenz Therapeutics(NASDAQ: LENZ) stock tumbled 11.2% through 9:50 a.m. ET Tuesday after missing on Q4 earnings. Heading into the report, analysts forecast Lenz to lose $0.90 per share on quarterly sales of $3.1 million. Lenz lost $1.16 per... Full story
Yahoo Finance • 21 days ago
LENZ Therapeutics GAAP EPS of -$1.16 misses by $0.26, revenue of $1.59M misses by $1.5M
* LENZ Therapeutics press release [https://seekingalpha.com/pr/20448519-lenz-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-recent] (LENZ [https://seekingalpha.com/symbol/LENZ]): Q4 GAAP EPS of -$1.16 misses... Full story
Yahoo Finance • 4 months ago
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
SAN DIEGO and TAIPEI, Taiwan, Dec. 01, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSW Stock Code: 1795) today announced that Lotus has submitted a New Drug Application (N... Full story
Yahoo Finance • 7 months ago
Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Continue Reading View Comments... Full story
Yahoo Finance • 8 months ago
LENZ Therapeutics stock price target raised to $56 from $48 at H.C. Wainwright
Investing.com - H.C. Wainwright raised its price target on LENZ Therapeutics Inc (NASDAQ:LENZ) to $56.00 from $48.00 on Friday, while maintaining a Buy rating on the stock. The company, currently trading at $39.85 with a market capitalizat... Full story
Yahoo Finance • 8 months ago
LENZ Therapeutics GAAP EPS of -$0.53 beats by $0.05
* LENZ Therapeutics press release [https://seekingalpha.com/pr/20182617-lenz-therapeutics-reports-second-quarter-2025-financial-results-and-recent-corporate] (NASDAQ:LENZ [https://seekingalpha.com/symbol/LENZ]): Q2 GAAP EPS of -$0.53 bea... Full story
Yahoo Finance • 9 months ago
LENZ Therapeutics gains on NDA submission in China for presbyopia drug LNZ100
LENZ Therapeutics (NASDAQ:LENZ [https://seekingalpha.com/symbol/LENZ]) said Monday that CORXEL Pharmaceuticals has submitted the new drug application for LNZ100 to the Center for Drug Evaluation of the National Medical Products Administrat... Full story
Yahoo Finance • 9 months ago
Noteworthy Wednesday Option Activity: META, CVNA, LENZ
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Meta Platforms Inc (Symbol: META), where a total volume of 348,474 contracts has been traded thus far today, a contract v... Full story
Yahoo Finance • 9 months ago
Lenz Therapeutics stock gains as William Blair reiterates Outperform
Investing.com - Lenz Therapeutics Inc (NASDAQ:LENZ) stock gained after William Blair reiterated its Outperform rating on the presbyopia treatment developer. The stock has shown strong momentum, rising nearly 11% in the past week, with anal... Full story
Yahoo Finance • 10 months ago
Versant sells LENZ therapeutics (LENZ) stock worth $10.1 million
Versant Venture Capital entities reported selling shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ), for a total of $10.1 million. The sales occurred at prices ranging from $29.95 to $30.35, near the current trading price of $29.94. The stoc... Full story
